PAVM - PAVmed Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
565
377
500
0
0
Cost of revenue
2,437
3,614
585
-
-
Gross profit
-1,872
-3,237
-85
-
-
Operating expenses
Research development
25,842
25,547
19,847
10,963
6,630
Selling general and administrative
57,133
60,359
34,461
12,388
7,665
Total operating expenses
84,230
87,690
54,308
23,351
14,295
Operating income or loss
-86,102
-90,927
-54,393
-23,351
-14,295
Interest expense
1,049
1,272
0
53
32.667
Total other income/expenses net
-11,194
-11,039
-1,733
-11,824
-2,390
Income before tax
-98,345
-103,238
-56,126
-35,888
-17,268
Income tax expense
0
0
0
0
0
Income from continuing operations
-98,345
-103,238
-56,126
-35,888
-17,268
Net income
-85,741
-88,983
-50,347
-34,276
-16,457
Net income available to common shareholders
-86,017
-89,264
-50,630
-34,563
-16,727
Basic EPS
-
-1.00
-0.65
-0.73
-0.55
Diluted EPS
-
-1.00
-0.65
-0.73
-0.55
Basic average shares
-
89,076
77,516
47,432
30,197
Diluted average shares
-
89,076
77,516
47,432
30,197
EBITDA
-
-99,509
-55,900
-35,812
-17,221